| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Annoucements
|
|
|
|
23 |
2 |
p. 757
|
artikel
|
| 2 |
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
|
Devreese, Katrien M.J.
|
|
|
23 |
2 |
p. 731-744
|
artikel
|
| 3 |
Application of platelet transcriptomics for assessing treatment effectiveness and predicting long-term platelet counts recovery in aplastic anemia
|
Mao, Jin
|
|
|
23 |
2 |
p. 692-703
|
artikel
|
| 4 |
Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces
|
Avery, Nathan G.
|
|
|
23 |
2 |
p. 513-524
|
artikel
|
| 5 |
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study
|
Giannotta, Juri Alessandro
|
|
|
23 |
2 |
p. 704-716
|
artikel
|
| 6 |
Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomized controlled trial
|
Hapgood, Greg
|
|
|
23 |
2 |
p. 627-634
|
artikel
|
| 7 |
Citrullination of tissue factor pathway inhibitor alpha by peptidylarginine deiminase 4 impairs its natural anticoagulant activity toward factors Xa and VIIa/tissue factor and reduces binding to its cofactor protein S
|
Bouwens, Bryan R.C.
|
|
|
23 |
2 |
p. 641-650
|
artikel
|
| 8 |
Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria
|
Dawwas, Ghadeer K.
|
|
|
23 |
2 |
p. 546-555
|
artikel
|
| 9 |
Comparing one stage, chromogenic assay results and discrepancies with bleeding phenotype and genetic variants in females with hemophilia A
|
Srivaths, Lakshmi
|
|
|
23 |
2 |
p. 504-512
|
artikel
|
| 10 |
Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’
|
McBane II, Robert D.
|
|
|
23 |
2 |
p. 756
|
artikel
|
| 11 |
Deconstructing fibrin(ogen) structure
|
Risman, Rebecca A.
|
|
|
23 |
2 |
p. 368-380
|
artikel
|
| 12 |
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
|
Goldenberg, Neil A.
|
|
|
23 |
2 |
p. 651-656
|
artikel
|
| 13 |
Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin
|
Patrignani, Paola
|
|
|
23 |
2 |
p. 397-400
|
artikel
|
| 14 |
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
|
Miyazawa, Kenji
|
|
|
23 |
2 |
p. 480-491
|
artikel
|
| 15 |
Guidelines and guidance: what is the path forward for the ISTH?
|
Ní Áinle, Fionnuala
|
|
|
23 |
2 |
p. 361-367
|
artikel
|
| 16 |
Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery
|
Todd, Kevin
|
|
|
23 |
2 |
p. 492-503
|
artikel
|
| 17 |
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models
|
Becattini, Cecilia
|
|
|
23 |
2 |
p. 754-755
|
artikel
|
| 18 |
“Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models”: comment
|
Bova, Carlo
|
|
|
23 |
2 |
p. 753
|
artikel
|
| 19 |
Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus
|
He, Liuchang
|
|
|
23 |
2 |
p. 565-576
|
artikel
|
| 20 |
Integrative phosphoproteomic analyses reveal hemostatic-endothelial signaling interplay
|
Groten, Stijn A.
|
|
|
23 |
2 |
p. 717-730
|
artikel
|
| 21 |
Intensive FVIII replacement in hemophilia patients with hypertrophic synovium: a randomized study
|
Di Minno, Matteo Nicola Dario
|
|
|
23 |
2 |
p. 458-465
|
artikel
|
| 22 |
Issue Information
|
|
|
|
23 |
2 |
p. e1-e6
|
artikel
|
| 23 |
Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration
|
Polzin, Amin
|
|
|
23 |
2 |
p. 668-683
|
artikel
|
| 24 |
Love for lysis in the time of catheters: is it time to resurrect an old standby?
|
Henkin, Stanislav
|
|
|
23 |
2 |
p. 401-403
|
artikel
|
| 25 |
Machine learning models for risk prediction of cancer-associated thrombosis: a systematic review and meta-analysis
|
Chen, Keya
|
|
|
23 |
2 |
p. 610-626
|
artikel
|
| 26 |
Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds
|
Ponzar, Nathan
|
|
|
23 |
2 |
p. 577-587
|
artikel
|
| 27 |
Molecular basis of platelet granule defects
|
Yao, Helen H.Y.
|
|
|
23 |
2 |
p. 381-393
|
artikel
|
| 28 |
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE
|
Kirienko, Alexander I.
|
|
|
23 |
2 |
p. 657-667
|
artikel
|
| 29 |
Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding
|
Lewandowska, Magdalena D.
|
|
|
23 |
2 |
p. 525-530
|
artikel
|
| 30 |
Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production
|
York, Elizabeth S.
|
|
|
23 |
2 |
p. 440-457
|
artikel
|
| 31 |
Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study
|
Skeith, Leslie
|
|
|
23 |
2 |
p. 429-439
|
artikel
|
| 32 |
Real-world safety and efficacy of rADAMTS13 in the treatment of congenital thrombotic thrombocytopenic purpura in pediatric patients in Poland
|
Laguna, Pawel
|
|
|
23 |
2 |
p. 635-640
|
artikel
|
| 33 |
Reuse, recycle, repurpose: pazopanib for bleeding in hereditary hemorrhagic telangiectasia
|
Al-Samkari, Hanny
|
|
|
23 |
2 |
p. 394-396
|
artikel
|
| 34 |
Risk assessment and management strategies in older patients with acute pulmonary embolism
|
Luijten, Dieuwke
|
|
|
23 |
2 |
p. 588-599
|
artikel
|
| 35 |
Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease
|
Weiss, Luisa
|
|
|
23 |
2 |
p. 531-545
|
artikel
|
| 36 |
Splanchnic vein thrombosis: management for the thrombosis specialist
|
Barnum, Kevin J.
|
|
|
23 |
2 |
p. 404-416
|
artikel
|
| 37 |
The dynamic range of immunoassays for heparin-induced thrombocytopenia
|
Nilius, Henning
|
|
|
23 |
2 |
p. 684-691
|
artikel
|
| 38 |
The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells
|
Bär, Isabel
|
|
|
23 |
2 |
p. 466-479
|
artikel
|
| 39 |
“Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations”: comment from Kitchen et al.
|
Kitchen, Matthew
|
|
|
23 |
2 |
p. 750-752
|
artikel
|
| 40 |
Thrombotic complications in pregnancy: a case-based review of the evidence
|
Merz, Lauren E.
|
|
|
23 |
2 |
p. 417-428
|
artikel
|
| 41 |
Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association - International Society on Thrombosis and Haemostasis - European Association for Hemophilia and Allied Disorders - European Stroke Organization Clinical Practice Guidance document
|
Escobar, Miguel
|
|
|
23 |
2 |
p. 745-749
|
artikel
|
| 42 |
Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism
|
Bikdeli, Behnood
|
|
|
23 |
2 |
p. 556-564
|
artikel
|
| 43 |
Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study
|
Lanting, Vincent
|
|
|
23 |
2 |
p. 600-609
|
artikel
|
Tijdschrift beschrijving